Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Benjamin R tenOever
Affiliation
NYU Grossman School of Medicine
ORCID
Career Start Year
2001
Papers
138
H Index
54
Expertise
CM4AI Collaborator
Kirsten Obernier (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37389976
SARS-CoV-2 and Influenza A Virus Induce Longitudinal Transcriptomic Changes in Hamster Spinal Cord Tissue.
Spine (Phila Pa 1976)
2024
36700640
Virology under the Microscope-a Call for Rational Discourse.
J Virol
2023
37914927
Mouse genome rewriting and tailoring of three important disease loci.
Nature
2023
37159520
SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model.
Sci Signal
2023
37017521
ADAR1 Biology Can Hinder Effective Antiviral RNA Interference.
J Virol
2023
37345956
SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.
mBio
2023
36943134
Archaeal Kink-Turn Binding Protein Mediates Inhibition of Orthomyxovirus Splicing Biology.
J Virol
2023
37311033
Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19.
Sci Signal
2023
37028415
Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA.
Mol Cell
2023
36918693
A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection.
Nat Cell Biol
2023
36869692
Nipah Virus Bangladesh Infection Elicits Organ-Specific Innate and Inflammatory Responses in the Marmoset Model.
J Infect Dis
2023
36631691
Innate immune evasion strategies of SARS-CoV-2.
Nat Rev Microbiol
2023
36700653
Virology under the Microscope-a Call for Rational Discourse.
mSphere
2023
36700642
Virology under the Microscope-a Call for Rational Discourse.
mBio
2023
35133984
Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection.
JCI Insight
2022
35653263
Pernio and early SARS-CoV-2 variants: natural history of a prospective cohort and the role of interferon.
Br J Dermatol
2022
35441168
SARS-CoV-2 hijacks host cell genome instability pathways.
Res Sq
2022
35610313
Cardiometabolic syndrome - an emergent feature of Long COVID?
Nat Rev Immunol
2022
35434541
Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy.
iScience
2022
35857629
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery.
Sci Transl Med
2022
35664254
Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids.
STAR Protoc
2022
35393414
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Nat Commun
2022
35862681
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
J Virol
2022
35714615
A diminished immune response underlies age-related SARS-CoV-2 pathologies.
Cell Rep
2022
36570071
Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path.
ACS Bio Med Chem Au
2022
36206731
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants.
Cell Stem Cell
2022
36064543
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility.
NPJ Genom Med
2022
36032984
SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model.
bioRxiv
2022
36032397
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity.
Mol Ther Nucleic Acids
2022
36282911
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.
Sci Signal
2022
36083891
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19.
Sci Immunol
2022
35255712
SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells.
Circ Res
2022
35180380
Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia.
Cell
2022
34935435
The Host Factor ANP32A Is Required for Influenza A Virus vRNA and cRNA Synthesis.
J Virol
2022
35027731
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.
Nat Cell Biol
2022
35233572
TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION.
bioRxiv
2022
35294338
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry.
Elife
2022
33147445
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
Cell
2021
33853355
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.
Circ Res
2021
33791724
Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance.
medRxiv
2021
33570490
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Elife
2021
33568513
Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
J Virol
2021
33594368
Disruption of nuclear architecture as a cause of COVID-19 induced anosmia.
bioRxiv
2021
33836156
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Cell
2021
33636110
Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection.
Stem Cell Reports
2021
33501440
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.
bioRxiv
2021
33577760
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
Immunity
2021
34879241
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.
Cell Metab
2021
34644531
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.
Stem Cell Reports
2021
34523966
The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.
J Virol
2021
1 - 50 of 138
Column Actions
Search
Recommended Authors
Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year
2017
Number of shared co-authors
14
Adam Hage
University of Texas Medical Branch
Career Start Year
2017
Number of shared co-authors
8
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year
2012
Number of shared co-authors
42
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
31
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
6
Siyuan Ding
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
4
Ferdinand Roesch
VA-MD Regional College of Veterinary Medicine, Virginia Tech
Career Start Year
2009
Number of shared co-authors
37
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year
2009
Number of shared co-authors
7
Maria Teresa S??nchez-Aparicio
Icahn School of Medicine at Mount Sinai
Career Start Year
2009
Number of shared co-authors
36
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2009
Number of shared co-authors
8
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
10
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
9
Priya Luthra
Trudeau Institute
Career Start Year
2007
Number of shared co-authors
14
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year
2006
Number of shared co-authors
2
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2005
Number of shared co-authors
7
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2005
Number of shared co-authors
5
Jan Rehwinkel
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year
2004
Number of shared co-authors
5
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year
2003
Number of shared co-authors
4
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year
2003
Number of shared co-authors
42
Priya S Shah
University of California davis
Career Start Year
2002
Number of shared co-authors
16
Sean C Proll
Fred Hutchinson Cancer Research Center
Career Start Year
2001
Number of shared co-authors
11
Megan L Shaw
Icahn School of Medicine at Mount Sinai
Career Start Year
2000
Number of shared co-authors
34
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year
2000
Number of shared co-authors
1
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
5
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year
1998
Number of shared co-authors
17
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
3
Abraham L Brass
University of Massachusetts Medical School
Career Start Year
1995
Number of shared co-authors
11
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
17
Raul Andino
University of California san francisco
Career Start Year
1981
Number of shared co-authors
15
Michael G Katze
University of Washington
Career Start Year
1978
Number of shared co-authors
15
row(s) 1 - 30 of 30
Collaborators
Benjamin E Nilsson-Payant
Hanover Medical School
Co-authored papers
21
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
17
David Sachs
Icahn School of Medicine at Mount Sinai
Co-authored papers
14
Jean K Lim
Icahn School of Medicine at Mount Sinai
Co-authored papers
11
Tuo Zhang
Weill Cornell Medical College.
Co-authored papers
10
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers
9
Alain C Borczuk
Co-authored papers
8
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers
7
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers
6
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Sara Cherry
University of Pennsylvania
Co-authored papers
5
Kristen J Brennand
Co-authored papers
5
Balaji Manicassamy
University of Iowa
Co-authored papers
5
Lewis C Cantley
Co-authored papers
5
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers
5
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
4
Yaron Tomer
Meyer Cancer Center
Co-authored papers
4
Tom Maniatis
College des medecins du Quebec
Co-authored papers
4
Schahram Akbarian
Co-authored papers
4
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Olivier Elemento
Meyer Cancer Center
Co-authored papers
4
Panos Roussos
Co-authored papers
4
Charles M Rice
Rockefeller University
Co-authored papers
4
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
3
Adrianus C M Boon
Co-authored papers
3
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers
3
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers
3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Andrew Pekosz
Co-authored papers
3
1 - 30